About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes

Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes

NCT00655044·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Novo Nordisk A/S

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Type 1 diabetes
Type 2 diabetes
Candidates of use of a basal insulin as part of their diabetes regimen

You may not be if

Unwilling to adhere to therapy or follow up
Pregnancy

The record

StatusCompleted

PhaseNo phase

Taking part3,637

StartedMay 2007

UpdatedOct 28, 2016

Conditions

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Where1

Novo Nordisk Investigational Site
Moscow, Russia